Arcim Institute
Filderstadt, Baden-Wurttemberg, 70794, Germany
NCT Number: NCT03256474
Retrospective cohort analysis of children hospitalized for pneumonia comparing disease severity on admission, clinical course, treatment and outcomes and prospective telephone based Follow-Up assessement.
Looking for future studies?
Notify MeUp to 18 year
All sexes
Observational
Filderstadt, Baden-Wurttemberg, 70794, Germany
The investigators will conduct a retrospective cohort analysis of children hospitalized for pneumonia at the Filderklinik between December 2006 and November 2010. The Bacterial Pneumonia Score, a validated composite laboratory, clinical and radiologic score developed by Moreno et al, will be retrospectively applied to define cases as either viral or bacterial pneumonia. The investigators will compare disease severity on admission, clinical course, and outcomes (in terms of complications, length of stay and readmission rates) between antimicrobial and non-antimicrobial managed bacterial pneumonia cases. Long-term Follow-Up will be assessed by telephone interviews with the parents.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Drugs, external applications like chest wraps, inhalations
Time frame: Between admission and 3 months after discharge
Cure rate of non-antimicrobial management of bacterial pneumonia (in the following and in the final publication, the term "bacterial pneumonia" will be used for children who fulfill the Moreno criteria for pneumonia): % of children managed without antimicrobials since admission, without subsequent need for antimicrobials or readmission.
Time frame: Between admission and 3 months after discharge
Medical complication rate among children with bacterial pneumonia, treated with or without antimicrobials
Time frame: Between admission and 3 months after discharge
Length of hospital stay for children with bacterial pneumonia, managed with or without antimicrobials
Time frame: 7 - 10 years after hospitalization
Readmission rate for pneumonia among children with bacterial pneumonia, managed with or without antimicrobials
Time frame: Between admission and 3 months after discharge
Days to temperature normalization (< 38°C) in children with bacterial pneumonia, managed with or without antimicrobials
Time frame: Between admission and 3 months after discharge
Days of supplemental oxygen need in children with bacterial pneumonia, managed with or without antimicrobials
Time frame: Between admission and 3 months after discharge
Changes in respiratory rate as an indicator for pulmonary infection
Time frame: Between admission and 3 months after discharge
Changes in Bacterial Pneumonia Score as an indicator for pulmonary infection
Time frame: Between admission and 3 months after discharge
Changes in oxygen saturation as an indicator for pulmonary infection
Time frame: Between admission and 3 months after discharge
Changes in CRP as an indicator for infection
Time frame: Between admission and 3 months after discharge
Changes in leukocyte count as an indicator for infection
Time frame: Between admission and 3 months after discharge
Changes in pH as an indicator for respiratory distress
Time frame: Between admission and 3 months after discharge
Changes in pCO2 as an indicator for respiratory distress
Time frame: Day of admission
Rate of chronic and acute-infectious co-morbidities on admission in children with bacterial pneumonia, subsequently managed with or without antimicrobials
Time frame: Between admission and 3 months after discharge
Utilization rate of a package of complementary treatment measures from anthroposophic medicine (including oral medications, inhalation and external nursing applications) in children managed with or without antimicrobials
Time frame: Between admission and 3 months after discharge
Antimicrobial treatment rate in children classified as viral pneumonia by Bacterial Pneumonia Score
Time frame: Between admission and 3 months after discharge
Number of patients treated with antipyretics
ARCIM Institute Academic Research in Complementary and Integrative Medicine
Other
Can Community-acquired Bacterial Pneumonia in Children be Safely Managed Without Antibiotics in an Integrative Medicine Context? A Retrospective Cohort Analysis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07552779
COVID-19, COVID-19 (Coronavirus Disease 2019)
Brussels, Bruxelles-capitale, Région de, Belgium
View Trial DetailsNCT07421440
Infections, Lung Diseases
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT05334316
Infections, Lung Diseases
Rochester, Minnesota, United States
View Trial DetailsNCT07070271
Infections, Lung Diseases
Giza, Egypt
View Trial Details